Sort   by:  
 Page size 
0
UnknownEvolocumab lowers LDL-C safely and effectively when self-administered in the at-home setting.
Not available
S-EPMC4783317 | biostudies-literature
0
UnknownReduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome.
Not available
S-EPMC9383814 | biostudies-literature
0
TranscriptomicsTranscription profiling of soybean roots at three time points after infection with soybean cyst nematodes
Parallel genome-wide expression profile of soybean and soybean cyst nematode at three points during infection 2, 5, 10 days post-inoculation.
ORGANISM(S): Glycine max 
2006-11-30 | E-MEXP-808 | biostudies-arrayexpress
0
UnknownDivergent evolution of arrested development in the dauer stage of Caenorhabditis elegans and the infective stage of Heterodera glycines.
Not available
S-EPMC2246285 | biostudies-literature
0
UnknownRomosozumab Enhances Vertebral Bone Structure in Women With Low Bone Density.
Not available
S-EPMC9299688 | biostudies-literature
0
TranscriptomicsTranscription profiling of soybean cyst nematode-induced syncytia in soybean - time series
Developmental expression profiling of SCN-induced syncytia in soybean (W82) during a compatible interaction.
ORGANISM(S): Glycine max 
2007-06-09 | E-MEXP-876 | biostudies-arrayexpress
0
UnknownSubgroup variations in bone mineral density response to zoledronic acid after hip fracture.
Not available
S-EPMC4307640 | biostudies-literature
0
UnknownInfluence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study.
Not available
S-EPMC5408481 | biostudies-literature
0
TranscriptomicsTranscription profiling of soybean cyst nematode (Heterodera glycines) throughout the nematode life cycle
Expression profiling of 7,530 Heterodera glycines probesets present on the Affymetrix Soybean Genome Array GeneChip throughout the life cycle of the nematode (egg, infective J2, parasitic J2, J3, J4, adult female).
ORGANISM(S): Heterodera glycines 
2007-10-20 | E-MEXP-1110 | biostudies-arrayexpress
0
UnknownRomosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial.
Not available
S-EPMC9292813 | biostudies-literature
Sort   by:  
 Page size